In the UK, the MenACWY vaccine is routinely offered to:

• Teenagers aged 13 to 18, including those in school years 9 to 13.
• First-time university students under the age of 25.
• Individuals with specific medical conditions or who are in close contact with someone who has a compromised immune system.
• Those travelling to Saudi Arabia for Hajj or Umrah

Meningococcal diseases can be severe and sometimes life-threatening. The MenACWY vaccine helps prevent these diseases by protecting against the four main types of meningococcal bacteria that are most likely to cause outbreaks in the UK.

The vaccine is given as an injection into the upper arm. For teenagers and young adults, it is usually provided in schools or through GP clinics.

Common side effects include redness or swelling at the injection site, mild fever, or feeling generally unwell. These side effects are typically short-lived and mild. Serious side effects are rare.

The MenACWY vaccine is highly effective in preventing disease caused by the types of meningococcal bacteria it targets. Immunity usually develops within two to three weeks after vaccination.

Yes, the MenACWY vaccine provides broader protection compared to the MenC vaccine alone. It is recommended for those who are eligible to ensure comprehensive protection against multiple strains of meningococcal bacteria.

If you missed your vaccination, contact your GP or local health services to arrange an appointment. It is important to catch up on vaccinations to ensure you are protected.

For more detailed information, you can refer to the NHS website and the Green Book.

The MenACWY vaccine is a requirement for individuals traveling to Saudi Arabia for Hajj or Umrah. This requirement is in place to protect pilgrims from meningococcal disease, which can be a risk in crowded settings. Travelers should receive the vaccine at least 10 days before their journey to ensure effective protection.